Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Non-Current Assets: 2015-2024

Historic Non-Current Assets for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $31.8 million.

  • Wave Life Sciences' Non-Current Assets fell 23.83% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year decrease of 23.83%. This contributed to the annual value of $31.8 million for FY2024, which is 19.62% down from last year.
  • Wave Life Sciences' Non-Current Assets amounted to $31.8 million in FY2024, which was down 19.62% from $39.6 million recorded in FY2023.
  • Wave Life Sciences' Non-Current Assets' 5-year high stood at $49.2 million during FY2020, with a 5-year trough of $31.8 million in FY2024.
  • Moreover, its 3-year median value for Non-Current Assets was $39.6 million (2023), whereas its average is $39.7 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first slumped by 50.19% in 2020, then climbed by 7.66% in 2022.
  • Yearly analysis of 5 years shows Wave Life Sciences' Non-Current Assets stood at $49.2 million in 2020, then fell by 9.66% to $44.4 million in 2021, then rose by 7.66% to $47.8 million in 2022, then dropped by 17.29% to $39.6 million in 2023, then declined by 19.62% to $31.8 million in 2024.